Wait a second I thought this thing had no downside
Early science good but manufacturing an issue for years. Disappointing that this has reared its head after being told we’d solved the issues.
- Forums
- ASX - By Stock
- Ann: Updated guidance for PAT-DX1 phase 1 clinical study
Wait a second I thought this thing had no downside Early science...
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
-0.001(7.14%) |
Mkt cap ! $13.37M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.6¢ | $264 | 42.41K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 6055648 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1726391 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 85000 | 0.007 |
19 | 5951722 | 0.006 |
21 | 8332226 | 0.005 |
8 | 4875000 | 0.004 |
8 | 6400016 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 84999 | 1 |
0.007 | 1726391 | 6 |
0.008 | 2000000 | 2 |
0.009 | 1766604 | 3 |
0.010 | 1412000 | 3 |
Last trade - 14.46pm 22/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |